Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/nrcardio.2016.216 http://scihub22266oqcxt.onion/10.1038/nrcardio.2016.216 C5880294!5880294!28094270     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28094270&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nat+Rev+Cardiol 2017 ; 14 (2): 71-2 Nephropedia Template TP {{tp|p=28094270|t=2017. Advances in new therapeutic targets for atherosclerosis |pdf=|usr=}}{{28094270}} gab.com Text Advances in new therapeutic targets for atherosclerosis JO: Nat Rev Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=28094270 #FOAvip In 2016, advances in atherosclerosis research were focused on the discovery and validation of new targets with genetic and mechanistic links to atherothrombotic heart disease. Novel targets include proteins involved in glycoprotein recognition and clearance, regulators of triglyceride-rich particle metabolism, inflammatory pathways that impair efferocytosis, and the gut microbiome. Twit Text FOAVip Advances in new therapeutic targets for atherosclerosis ????Nat Rev Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=28094270 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28094270 #FOAvip English Wikipedia <ref>{{Cite pmid|28094270}}</ref> Advances in new therapeutic targets for atherosclerosis #MMPMID28094270 Wilson Tang WH; Hazen SL Nat Rev Cardiol 2017[Jan]; 14 (2): 71-2 PMID28094270show ga In 2016, advances in atherosclerosis research were focused on the discovery and validation of new targets with genetic and mechanistic links to atherothrombotic heart disease. Novel targets include proteins involved in glycoprotein recognition and clearance, regulators of triglyceride-rich particle metabolism, inflammatory pathways that impair efferocytosis, and the gut microbiome. äAdvances in new therapeutic targets for atherosclerosis (epmc).pdf DeepDyve Pubget Overpricing